Cargando…
Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China
OBJECTIVE: To evaluate the cost-effectiveness of lurasidone compared with olanzapine and risperidone in the first-line treatment of patients with schizophrenia from a Chinese healthcare system perspective. METHODS: A Markov model with 6-week cycle was constructed to reflect the disease progression o...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521600/ https://www.ncbi.nlm.nih.gov/pubmed/36187655 http://dx.doi.org/10.3389/fpubh.2022.987408 |